Search for Clinical Trial Results

Sponsored By

Herpes Simplex - 30 Studies Found

Status Study
Withdrawn Study Name: A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)
Condition: Herpes Simplex Virus
Date: 2012-05-30
Interventions:
  • Drug: Novel Antiviral Drug 4 o
Completed Study Name: Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection
Condition: Herpes Simplex
Date: 2000-02-24
Interventions: Drug: acyclovir
Completed Study Name: Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth
Condition: Herpes Simplex
Date: 2000-02-24
Interventions: Drug: acyclovir
Completed Study Name: Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth
Condition: Herpes Simplex
Date: 2002-03-06
Interventions:
  • Drug: Acyclovir Oral suspensio
Completed Study Name: Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates
Condition: Herpes Simplex
Date: 2002-03-06
Interventions:
  • Drug: Acyclovir Oral banana fl
Completed Study Name: Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China
Condition:
  • Influenza A Virus Infection
  • Influenza B Virus Infection

Date: 2011-10-21
Interventions:
  • Drug: Zanamivir 10 mg inhaled

Not yet recruiting Study Name: Liver Injury by Statins in Patients With History of Hepatitis B Virus Infection
Condition:
  • Liver Injury
  • Hepatitis B Virus Infection History

Date: 2016-06-17
Interventions: Other: HBV infection history HBV infection history or HBV carriers
Completed Study Name: Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-Positive Adults
Condition: Prophylaxis Herpes Simplex
Date: 2008-06-13
Interventions: Biological: Herpes simplex candidate (gD) vaccine GSK208141 Intramuscular injection, 2 doses, 2 differen
Completed Study Name: Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
Condition: Prophylaxis Herpes Simplex
Date: 2008-06-12
Interventions:
  • Biological: Herpes simplex candidate vaccine GSK208141 - non-MPL-containing

Completed Study Name: Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines
Condition: Prophylaxis Herpes Simplex
Date: 2008-06-13
Interventions:
  • Biological: Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141

Next >>>